MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Neuraxis (NRXS) Ownership - Who owns Neuraxis?
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Profile
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
27.15M
P/E Ratio
N/A
Total Cash
5.99M
Projected Growth
N/A
Total Debt
410.48K
Revenue
3.22M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
0.43 USD as % of share price
Fundamentals
NRXS
Capitalization
27.2M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
5.99M
Total Cash/Share
0.61
Total Debt
410K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.43%
Revenue
3.22M
ROE
N/A
Book Value
4.25M
P/B Ratio
6.39
Cash Flow
N/A
Earnings
-1.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9.86K
Current Ratio
2.82
Current Revenue Per Employee
42575.52
Dividends Per Share - Security
N/A
EBITDA
-7.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.60
Revenue To Assets
-160.56
Shares Held By Institutions
2.24M
Shares Outstanding - Current
9.87M
Total Liabilities
2.84M
Total Volume MTD
N/A
Value
N/A
Gain YTD
17.021
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRXS showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com